BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:51 PM
Feb 04, 2010
 |  BC Extra  |  Company News

Qiagen, Pfizer to develop companion diagnostic

Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN) partnered with Pfizer Inc. (NYSE:PFE) to develop a companion diagnostic for Pfizer's cancer vaccine PF-04948568 ( CDX-110). The vaccine targeting

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >